JP7326295B2 - オキサゾール化合物結晶 - Google Patents
オキサゾール化合物結晶 Download PDFInfo
- Publication number
- JP7326295B2 JP7326295B2 JP2020539109A JP2020539109A JP7326295B2 JP 7326295 B2 JP7326295 B2 JP 7326295B2 JP 2020539109 A JP2020539109 A JP 2020539109A JP 2020539109 A JP2020539109 A JP 2020539109A JP 7326295 B2 JP7326295 B2 JP 7326295B2
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- type
- compound
- crystals
- infrared absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021196978A JP2022037040A (ja) | 2018-04-04 | 2021-12-03 | オキサゾール化合物結晶 |
| JP2023171778A JP2024001115A (ja) | 2018-04-04 | 2023-10-03 | オキサゾール化合物結晶 |
| JP2025093100A JP2025128238A (ja) | 2018-04-04 | 2025-06-04 | オキサゾール化合物結晶 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018072717 | 2018-04-04 | ||
| JP2018072717 | 2018-04-04 | ||
| PCT/JP2019/014730 WO2019194211A1 (en) | 2018-04-04 | 2019-04-03 | Oxazole compound crystal |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021196978A Division JP2022037040A (ja) | 2018-04-04 | 2021-12-03 | オキサゾール化合物結晶 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021517111A JP2021517111A (ja) | 2021-07-15 |
| JP2021517111A5 JP2021517111A5 (cg-RX-API-DMAC7.html) | 2021-08-26 |
| JP7326295B2 true JP7326295B2 (ja) | 2023-08-15 |
Family
ID=66223774
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539109A Active JP7326295B2 (ja) | 2018-04-04 | 2019-04-03 | オキサゾール化合物結晶 |
| JP2021196978A Pending JP2022037040A (ja) | 2018-04-04 | 2021-12-03 | オキサゾール化合物結晶 |
| JP2023171778A Pending JP2024001115A (ja) | 2018-04-04 | 2023-10-03 | オキサゾール化合物結晶 |
| JP2025093100A Pending JP2025128238A (ja) | 2018-04-04 | 2025-06-04 | オキサゾール化合物結晶 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021196978A Pending JP2022037040A (ja) | 2018-04-04 | 2021-12-03 | オキサゾール化合物結晶 |
| JP2023171778A Pending JP2024001115A (ja) | 2018-04-04 | 2023-10-03 | オキサゾール化合物結晶 |
| JP2025093100A Pending JP2025128238A (ja) | 2018-04-04 | 2025-06-04 | オキサゾール化合物結晶 |
Country Status (26)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024001115A (ja) * | 2018-04-04 | 2024-01-09 | 大塚製薬株式会社 | オキサゾール化合物結晶 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4501324A4 (en) | 2022-03-25 | 2026-04-08 | Otsuka Pharma Co Ltd | WOUND TREATMENT COMPOSITION |
| CN115887463A (zh) * | 2022-12-27 | 2023-04-04 | 瑞石生物医药有限公司 | 一种含环酰胺化合物的药物组合物 |
| GB202306663D0 (en) | 2023-05-05 | 2023-06-21 | Union Therapeutics As | Combination therapy |
| US20260076788A1 (en) * | 2024-09-17 | 2026-03-19 | Natalie DeVoir | Orthodontic composition |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017115780A1 (en) | 2015-12-28 | 2017-07-06 | Otsuka Pharmaceutical Co., Ltd. | Ointment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI330639B (en) * | 2005-11-15 | 2010-09-21 | Otsuka Pharma Co Ltd | Oxazole compound and pharmaceutical composition |
| EP2890686B1 (en) * | 2012-08-30 | 2017-01-04 | Otsuka Pharmaceutical Co., Ltd. | Method for producing oxazole compound |
| PL3774745T3 (pl) * | 2018-04-04 | 2024-08-19 | Otsuka Pharmaceutical Co., Ltd. | Kryształ cząsteczki oksazolu |
-
2019
- 2019-04-03 PL PL19718465.8T patent/PL3774745T3/pl unknown
- 2019-04-03 TW TW108111946A patent/TWI860993B/zh active
- 2019-04-03 PT PT197184658T patent/PT3774745T/pt unknown
- 2019-04-03 JP JP2020539109A patent/JP7326295B2/ja active Active
- 2019-04-03 IL IL315425A patent/IL315425A/en unknown
- 2019-04-03 WO PCT/JP2019/014730 patent/WO2019194211A1/en not_active Ceased
- 2019-04-03 EP EP24172132.3A patent/EP4400167A3/en active Pending
- 2019-04-03 TW TW113146840A patent/TW202515853A/zh unknown
- 2019-04-03 MX MX2020010435A patent/MX2020010435A/es unknown
- 2019-04-03 EA EA202092393A patent/EA202092393A1/ru unknown
- 2019-04-03 CA CA3095866A patent/CA3095866A1/en active Pending
- 2019-04-03 HU HUE19718465A patent/HUE066793T2/hu unknown
- 2019-04-03 MY MYPI2020005118A patent/MY202406A/en unknown
- 2019-04-03 LT LTEPPCT/JP2019/014730T patent/LT3774745T/lt unknown
- 2019-04-03 FI FIEP19718465.8T patent/FI3774745T3/fi active
- 2019-04-03 KR KR1020207031251A patent/KR102764726B1/ko active Active
- 2019-04-03 AU AU2019249562A patent/AU2019249562B2/en active Active
- 2019-04-03 SG SG11202009564TA patent/SG11202009564TA/en unknown
- 2019-04-03 US US17/044,892 patent/US11414391B2/en active Active
- 2019-04-03 DK DK19718465.8T patent/DK3774745T3/da active
- 2019-04-03 CN CN201980022064.2A patent/CN111902402B/zh active Active
- 2019-04-03 ES ES19718465T patent/ES2982586T3/es active Active
- 2019-04-03 EP EP19718465.8A patent/EP3774745B1/en active Active
- 2019-04-03 HR HRP20240858TT patent/HRP20240858T1/hr unknown
- 2019-04-03 KR KR1020257003493A patent/KR20250022254A/ko active Pending
- 2019-04-03 IL IL277730A patent/IL277730B2/en unknown
- 2019-04-03 BR BR112020019377-1A patent/BR112020019377A2/pt active Search and Examination
- 2019-04-03 SI SI201930776T patent/SI3774745T1/sl unknown
-
2020
- 2020-09-30 PH PH12020551605A patent/PH12020551605A1/en unknown
- 2020-10-02 ZA ZA2020/06134A patent/ZA202006134B/en unknown
-
2021
- 2021-12-03 JP JP2021196978A patent/JP2022037040A/ja active Pending
-
2022
- 2022-07-07 US US17/859,675 patent/US11840512B2/en active Active
-
2023
- 2023-10-03 JP JP2023171778A patent/JP2024001115A/ja active Pending
- 2023-10-31 US US18/498,894 patent/US20240076275A1/en not_active Abandoned
-
2024
- 2024-09-24 AU AU2024220015A patent/AU2024220015B2/en active Active
-
2025
- 2025-03-27 US US19/092,743 patent/US20250250243A1/en active Pending
- 2025-06-04 JP JP2025093100A patent/JP2025128238A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017115780A1 (en) | 2015-12-28 | 2017-07-06 | Otsuka Pharmaceutical Co., Ltd. | Ointment |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024001115A (ja) * | 2018-04-04 | 2024-01-09 | 大塚製薬株式会社 | オキサゾール化合物結晶 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001115A (ja) | オキサゾール化合物結晶 | |
| RU2631321C2 (ru) | Кристаллическая форма i дималеата ингибитора тирозинкиназы и способ ее получения | |
| JP2025114691A (ja) | オキサゾール化合物結晶 | |
| JP4944612B2 (ja) | トシル酸スプラタスト結晶の均一性の評価方法並びに均一な結晶及びその製造方法 | |
| HK40040843A (en) | Oxazole compound crystal | |
| HK40113056A (en) | Oxazole compound crystal | |
| JP7689778B2 (ja) | ペプチドボロン酸系化合物の新規な結晶形およびその調製方法 | |
| HK40036102B (en) | Oxazole compound crystal | |
| HK40036102A (en) | Oxazole compound crystal | |
| EA042645B1 (ru) | Кристаллическое соединение оксазола |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201009 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210715 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20210715 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210803 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210824 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210907 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20211203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20211203 |
|
| C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230110 |
|
| C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230322 |
|
| C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20230404 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230518 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230802 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7326295 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |